You mean the regulations that limit competition in the US and restrict manufactures and grant monopoly rights? These are the regulations that are good right?
What are you talking about when it comes to manufacturing insulin? I mean, yes, I definitely do want regulations around the safety of drug manufacturing, but beyond that what regulations specifically are you referring to that restrict the manufacturing of insulin?
>The second reason, the authors noted, is that there isn't significant competition in the U.S. insulin market. Price competition typically comes from the introduction of a generic drug that directly competes with a branded product.
>But the authors said that current insulin makers have blocked the entry to such products by getting new patents based on things such as a new delivery device.
